{"hq_id":"hq-p-bdy-000171","name":"Mercury Amalgam Dental Fillings — Minamata Convention Phase-Down, Elemental Mercury Vapor Exposure, FDA Class II Device (Hg0 Off-Gassing, Occupational Risk)","category":{"primary":"oral_care","secondary":"dental_restoration","tags":["mercury","amalgam","dental filling","Minamata Convention","mercury vapor","Hg0","FDA Class II","occupational exposure","silver filling"]},"product_tier":"BDY","overall_risk_level":"moderate","description":"Dental amalgam, composed of approximately 50% elemental mercury (Hg0) mixed with silver, tin, copper, and zinc alloy powder, has been used in over 1 billion fillings worldwide since the 1830s. The material continuously releases low-level mercury vapor during chewing, bruxism, and hot food/beverage consumption — studies using intra-oral mercury vapor analyzers demonstrate 1-3 micrograms Hg0/day from a typical amalgam-bearing dentition (8-10 fillings), contributing an estimated 50-70% of total mercury body burden in amalgam patients. The WHO confirmed in 2003 that dental amalgam is the largest single source of mercury exposure in non-occupationally exposed individuals. The 2013 Minamata Convention on Mercury (ratified by 140+ countries) mandates a phase-down of dental amalgam use, with specific prohibitions for children under 15, pregnant women, and breastfeeding women in EU Regulation 2017/852. The FDA classifies amalgam as a Class II medical device and issued a 2020 safety communication recommending alternatives for sensitive populations. Occupational exposure to dental personnel during amalgam placement and removal is a separate significant concern.","synthesis":{"derived_risk_level":"moderate_to_high","synthesis_confidence":0.88,"synthesis_method":"compound_composition","context_used":"human_child","context_source":"product_users","exposure_modifier":1,"vulnerability_escalated":true,"escalation_reason":"Child exposure group","compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-03-27","synthesis_version":"1.0.0"},"hazard_summary":{"sensitive_populations":"pregnant women (transplacental transfer), children under 15, patients with kidney disease (impaired mercury excretion), patients with neurological conditions, dental professionals","overall_risk":"moderate","primary_concerns":["Continuous mercury vapor release from amalgam fillings (1-3 ug/day average)","Dental amalgam is the largest single source of mercury exposure in general population (WHO 2003)","Minamata Convention mandates global phase-down; EU bans use in children under 15 and pregnant women","Occupational exposure to dental personnel during placement and removal procedures"],"exposure_routes":"Inhalation (primary — mercury vapor released during chewing, bruxism, hot beverage consumption). Ingestion (abraded amalgam particles swallowed)."},"exposure":{"routes":["inhalation","ingestion"],"contact_types":["inhalation_chronic","ingestion_incidental"],"users":["adult","child","dental_professional"],"duration":"chronic","frequency":"continuous","scenarios":["Patient: chronic low-level Hg0 vapor inhalation from amalgam fillings during chewing and bruxism","Pregnant woman: transplacental mercury transfer to fetus from maternal amalgam fillings","Dental professional: acute Hg0 vapor exposure during amalgam placement and removal (drilling generates aerosol)","Cremation: mercury release from dental amalgam during cremation (~3-5 g per body with amalgam fillings)"],"notes":"Mercury vapor mechanism: Hg0 is released from amalgam surfaces through mechanical abrasion (chewing), electrochemical corrosion (galvanic currents between dissimilar metals), and thermal stimulation (hot beverages). Uptake: Hg0 vapor is 80% absorbed through pulmonary alveoli, crosses blood-brain barrier. Urinary mercury levels: amalgam patients typically 2-5 ug/L vs <1 ug/L in amalgam-free individuals. WHO (2003): dental amalgam is the greatest source of mercury exposure for most people. Minamata Convention Article 4, Annex A, Part II: parties shall phase down dental amalgam use. FDA 2020 safety communication: recommended alternatives for pregnant women, nursing mothers, children under 6, people with kidney disease, those with neurological conditions."},"consumer_guidance":{"usage_warning":"The FDA recommends considering alternatives to amalgam for pregnant women, nursing mothers, children under 6, people with kidney disease, and those with pre-existing neurological conditions. If you have existing amalgam fillings, the FDA and ADA do not recommend removal solely to reduce mercury exposure — removal generates more acute mercury vapor exposure than leaving fillings in place. If amalgam removal is necessary (for dental reasons), ensure your dentist uses high-volume evacuation, rubber dam isolation, and proper ventilation.","safer_alternatives":["Composite resin fillings (BPA-free formulations available)","Glass ionomer cement (fluoride-releasing, suitable for some applications)","Ceramic/porcelain inlays and onlays (metal-free, durable)","Gold alloy restorations (biocompatible, long-lasting, higher cost)"]},"regulatory":{"applicable_regulations":[{"jurisdiction":"International","regulation":"Minamata Convention on Mercury — Dental Amalgam Phase-Down (Article 4, Annex A Part II)","citation":"Minamata Convention on Mercury (2013); UNEP; Article 4, Annex A, Part II","requirements":"Parties shall take measures to phase down dental amalgam use, including: promoting prevention to reduce need for fillings, promoting research into alternatives, restricting use in deciduous teeth and children, and encouraging insurance policies that do not favor amalgam over alternatives. 140+ countries ratified as of 2025.","compliance_status":null,"effective_date":"2017-08-16","enforcing_agency":"UNEP Secretariat of the Minamata Convention","penalties":null,"source_ref":null}],"certifications":[],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":true,"disposal_guidance":"Dental offices must use amalgam separators per EPA 2017 Dental Rule (40 CFR Part 441). Removed amalgam is recycled through licensed mercury recovery facilities. NEVER dispose of amalgam in regular trash or wastewater.","hazardous_waste":true,"expected_lifespan":"15-30 years average clinical longevity (longest-lasting direct restorative material)"},"formulation":{"form":"varies","key_ingredients":[],"certifications":[]},"materials":{"common":[],"concerning":[],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-ino-000046","compound_name":null,"role":"primary_component","typical_concentration":"~50% elemental mercury (Hg0); continuous vapor release 1-3 ug/day from average amalgam dentition"}],"identifiers":{"common_names":["mercury amalgam dental fillings — minamata convention phase-down, elemental mercury vapor exposure, fda class ii device (hg0 off-gassing, occupational risk)"],"aliases":[],"manufacturer":null,"brands":[]},"brand_examples":[],"sources":[{"type":"expert_curation","name":"ALETHEIA Safety Database","date":"2026-03-26"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-26","timestamp":"2026-05-02T18:16:10.584Z"}}